Organogenesis Holdings vs UFP Technologies
Organogenesis Holdings and UFP Technologies are similar in size: $564m and $603m of revenue in their latest fiscal years. UFP Technologies grew faster (19.5% against 17.0%). UFP Technologies kept more of each dollar of sales as profit: a net margin of 11.3% against 6.6%.
| Latest fiscal year | Organogenesis HoldingsORGO, 2025 | UFP TechnologiesUFPT, 2025 |
|---|---|---|
| Revenue | $564m | $603m |
| Revenue growth | 17.0% | 19.5% |
| Net income | $37.0m | $68.3m |
| Operating margin | 7.9% | — |
| Net margin | 6.6% | 11.3% |
| Return on equity | 13.2% | 17.8% |
| Free cash flow | −$24.5m | $91.9m |
| Cash | $93.7m | $20.3m |
| Total debt | $0 | $135m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 854 | 4,846 |
| Market value | $109m | $2.19bn |
| Price vs our value range | — | Within our value range |
| Moat score | 56 (Moderate) | 60 (Moderate) |
| Insider trades, 12 months | 2 buys, 4 sales | 0 buys, 27 sales |